Your browser doesn't support javascript.
loading
Advanced glycation end products derived from serum albumin modification by glucose (AGE-1) reflect clustering of lipid-associated metabolic abnormalities and are decreased in patients treated with acarbose: A cross-sectional study.
Bronowicka-Szydelko, Agnieszka; Krzystek-Korpacka, Malgorzata; Kuzan, Aleksandra; Gostomska-Pampuch, Kinga; Gacka, Malgorzata; Jakobsche-Policht, Urszula; Adamiec, Rajmund; Gamian, Andrzej.
Afiliação
  • Bronowicka-Szydelko A; Department of Medical Biochemistry, Wroclaw Medical University, Poland.
  • Krzystek-Korpacka M; Department of Medical Biochemistry, Wroclaw Medical University, Poland.
  • Kuzan A; Department of Medical Biochemistry, Wroclaw Medical University, Poland.
  • Gostomska-Pampuch K; Department of Medical Biochemistry, Wroclaw Medical University, Poland.
  • Gacka M; Department of Angiology, Diabetes and Hypertension, Wroclaw Medical University, Poland.
  • Jakobsche-Policht U; Department of Angiology, Diabetes and Hypertension, Wroclaw Medical University, Poland.
  • Adamiec R; Department of Angiology, Diabetes and Hypertension, Wroclaw Medical University, Poland.
  • Gamian A; Department of Medical Biochemistry, Wroclaw Medical University, Poland.
Adv Clin Exp Med ; 29(3): 275-284, 2020 03.
Article em En | MEDLINE | ID: mdl-32207583

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Albumina Sérica / Produtos Finais de Glicação Avançada / Acarbose / Diabetes Mellitus Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Albumina Sérica / Produtos Finais de Glicação Avançada / Acarbose / Diabetes Mellitus Idioma: En Ano de publicação: 2020 Tipo de documento: Article